5 Contradicted by research
There are approximately 80,000 dopamine neurons per side (about 160,000 total) in the human brainstem.
"and dopamine neurons in your brainstem are maybe 80,000 neurons per side, 160,000 neurons." (said at 0:33:00)
The speaker significantly underestimates the number of dopamine neurons in the human brainstem. Unbiased stereological postmortem investigations of the human substantia nigra indicate that normal human control brains contain approximately 400,000 to 550,000 pigmented (neuromelanin-containing dopaminergic) neurons in total (roughly 200,000 to 275,000 per side), not 80,000 per side or 160,000 total. When including the ventral tegmental area and other midbrain dopaminergic populations, the total count is even higher.
Patients with essential tremor do not experience a loss of dopamine, and administering dopaminergic drugs to them worsens their tremors.
"Essential tremors is like Parkinson's disease. You have tremors and you have difficulty with movement and whatnot. I don't think you have the emotional problems that Parkinson's patients do, but it's not Parkinson's. You have not lost dopamine. If you give an essential tremor patient dopamine drugs like they do Parkinson's patients, they get much worse." (said at 1:30:40)
The claim combines two assertions: one correct and one contradicted by evidence. First, the speaker accurately notes that essential tremor (ET) does not involve the characteristic nigrostriatal dopaminergic degeneration seen in Parkinson's disease, which is why dopamine imaging (such as 18F-DOPA PET or DaTscan) is standardly normal in ET and used to distinguish it from Parkinson's. However, the speaker's second assertion—that giving dopaminergic medications (such as levodopa) to ET patients makes them 'get much worse'—is contradicted by clinical evidence. Studies examining patients with ET or normal substantia nigra who were treated with levodopa show that dopaminergic agents simply provide no objective motor benefit and are ineffective, rather than causing marked symptom worsening.
- contradicts: Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and patholo… (Parkinsonism & related disorders 2015) · cited 8x in the literature
"Between 1968 and 2014, 21 cases treated with levodopa had normal substantia nigra at autopsy. Eleven patients continued levodopa until death and 9 received the drug for four years or longer. No objective motor symptom benefit, dyskinesia or motor response fluctuations on levodopa were observed in any case. The most common final diagnosis was essential tremor." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Current status and future challenges of brain imaging with (18)F-DOPA PET for movement dis… (Hellenic journal of nuclear medicine 2016) · cited 26x in the literature
"Parkinson's disease (PD) is a neurodegenerative disorder (ND) due to progressive loss of dopaminergic neurons in the basal ganglia. The correct differential diagnosis of this disease with parkinsonian syndromes (PS) or with essential tremor (ET) is a diagnostic dilemma, considering that only PD is responsive to treatment with levodopa." (abstract, results, passage verified)
pubmedfull study (doi) - context: Tips and tricks in tremor treatment. (Journal of neural transmission (Vienna, Austria : 1996) 2024) · cited 2x in the literature
"Levodopa remains pivotal for Parkinson's tremor, though response variability exists. Some dopamine agonists offer notable tremor reduction targeting D2 receptors. Propranolol effectively manages essential tremor and essential tremor plus (ET/ET +), sometimes with primidone for added benefits" (abstract, results, passage verified)
pubmedfull study (doi)
Dopamine binds to monoamine oxidase on the outer surface of mitochondria to initiate electron transport and increase ATP availability.
"It literally turns on mitochondria. It binds to the outside of mitochondria to monoamine oxidase and it initiate it gens up electron transport. I mean, it makes It's a signal to make ATP available." (said at 2:04:21)
While monoamine oxidase (MAO) is located on the outer mitochondrial membrane, dopamine does not bind MAO to stimulate the electron transport chain or increase ATP availability. Instead, MAO enzymatic oxidation of dopamine produces hydrogen peroxide, toxic aldehydes (such as DOPAL), and reactive oxygen species that inhibit respiratory chain complexes (notably complex I / NADH dehydrogenase) and impair mitochondrial respiration and ATP synthesis.
- contradicts: Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits c… (Neuropharmacology 2015) · cited 13x in the literature
"Taken together, these findings point to the formation of hydrogen peroxide subsequent to DA metabolism by MAO, rather than a direct DA-mediated mitochondrial complex I inhibition, and the contribution of a peripheral metabolite of MDMA, as the key steps in the chain of biochemical events leading to DA neurotoxicity caused by MDMA in mice." (abstract, passage verified)
pubmedfull study (doi) - contradicts: Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mi… (Journal of neural transmission (Vienna, Austria : 1996) 2024) · cited 19x in the literature
"Vice versa, dopamine oxidation by monoamine oxidase produces toxic aldehydes, reactive oxygen species, and quinones, which modify α-synuclein, and promote its fibril production and accumulation in mitochondria. Excessive dopamine in experimental models modifies proteins in the mitochondrial electron transport chain and inhibits the function." (abstract)
pubmedfull study (doi) - contradicts: Dopamine neurotoxicity: inhibition of mitochondrial respiration. (Journal of neurochemistry 1995) · cited 287x in the literature
"Indeed, dopamine inhibited mitochondrial NADH dehydrogenase activity with IC50 = 8 microM, and that of norepinephrine was twice as much (IC50 = 15 microM)." (abstract, passage verified)
pubmedfull study (doi)
Caucasian Olympic sprinters who won were exclusively from Eastern bloc countries.
"Caucasian sprinters in the Olympics that won were only from the Eastern bloc countries." (said at 2:34:18)
The claim that Caucasian Olympic sprint champions were exclusively from Eastern bloc countries is contradicted by Olympic historical records. Multiple Caucasian sprinters from Western nations have won Olympic sprint gold medals. For example, in the men's 100 metres alone, champions from outside the Eastern bloc include Harold Abrahams (Great Britain, 1924), Percy Williams (Canada, 1928), Bobby Morrow (USA, 1956), Armin Hary (United Team of Germany / West Germany, 1960), and Allan Wells (Great Britain, 1980). Similarly, in the 200 metres, champions include Livio Berruti (Italy, 1960) and Pietro Mennea (Italy, 1980), alongside numerous Western female Olympic sprint champions such as Fanny Blankers-Koen (Netherlands, 1948) and Betty Cuthbert (Australia, 1956).
There are approximately 80 different serotonin receptors.
"there probably what, 80 serotonin receptors or something. There's there's a there's a great um number of them." (said at 2:36:34)
The speaker claimed that there are approximately 80 different serotonin receptors. According to the authoritative IUPHAR (International Union of Basic and Clinical Pharmacology) classification, there are 14 distinct serotonin (5-HT) receptor subtypes, categorized across 7 main families (5-HT1 to 5-HT7). Stating that there are ~80 distinct serotonin receptors significantly overstates the actual number of known receptor subtypes.
6 Needs context
SSRIs increase levels of serotonin, but that serotonin is often utilized at dopamine synapses to reduce the rewarding properties of dopamine.
"As Read points out, SSRIs increase levels of serotonin, but often that serotonin gets used at the dopamine synapses to reduce the rewarding properties of dopamine." (said at 0:00:33)
The host's statement captures the well-established cross-talk between serotonin (5-HT) and dopamine (DA) pathways, particularly how increased extracellular serotonin (such as that induced by SSRIs) acts on inhibitory serotonergic receptors (notably 5-HT2C receptors located on dopaminergic or GABAergic interneurons in the ventral tegmental area and striatum) to suppress dopamine release and downstream reward processing. However, describing this as serotonin being 'utilized at dopamine synapses' is a simplified and slightly loose colloquial phrasing of heteroreceptor modulation across interconnected serotonergic and dopaminergic neural circuits.
- context: Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. (Pharmacology & therapeutics 2007) · cited 659x in the literature
"Studies show that serotonin (5-HT) acts through several 5-HT receptors in the brain to modulate DA neurons in all 3 major dopaminergic pathways... Several subtypes, including the 5-HT1A, 5-HT1B, 5-HT2A, 5-HT3 and 5-HT4 receptors, act to facilitate DA release, while the 5-HT2C receptor mediates an inhibitory effect of 5-HT on DA release." (abstract, results)
pubmedfull study (doi) - context: Activation of Ventral Tegmental Area 5-HT 2C Receptors Reduces Incentive Motivation. (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2017) · cited 60x in the literature
"These results indicate that activation of the subpopulation of 5-HT 2C R neurons within the VTA is sufficient to significantly reduce homeostatic feeding and effort-based intake of palatable food, and that this subset has an inhibitory role in motivational processes." (abstract, results, passage verified)
pubmedfull study (doi)
By the time a patient presents with clinical symptoms of Parkinson's disease, they have lost 70% to 75% of the dopamine neurons in their brainstem.
"Parkinson's disease is a condition where by the time you show up with symptoms in the doctor's office, you've lost 70 to 75% of your dopamine neurons in your brainstem." (said at 0:31:53)
The speaker's statement reflects a classic and widely cited rule of thumb in neurology regarding dopamine deficiency at the onset of Parkinson's disease motor symptoms, but it conflates striatal dopamine/terminal loss with midbrain substantia nigra dopaminergic cell body loss. Landmark post-mortem neuropathology studies (e.g., Fearnley & Lees 1991) estimate that at the onset of clinical motor symptoms, there is approximately a 50% to 68% loss of pigmented dopaminergic neurons in the substantia nigra pars compacta (specifically ~68% in the vulnerable lateral ventral tier and ~48% in the caudal nigra overall). The higher figure of 70% to 80% loss typically refers to striatal dopamine content or putaminal dopaminergic terminal loss rather than total substantia nigra neuronal cell bodies.
Brainstem dopamine neurons are the only source of dopamine in the brain except for a small pathway in the hypothalamus and pituitary.
"Those are the only source of dopamine in your brain except for a tiny pathway in your hypothalamus and pituitary." (said at 0:32:15)
The speaker correctly identifies the major dopaminergic projection systems of the central nervous system: the midbrain/brainstem groups (substantia nigra pars compacta and ventral tegmental area, giving rise to the nigrostriatal, mesolimbic, and mesocortical pathways) and the hypothalamic tuberoinfundibular pathway regulating prolactin secretion. However, describing these as the exclusive sources of dopamine in the central nervous system is an oversimplification. Well-characterized populations of dopamine-synthesizing neurons also reside outside the midbrain and tuberoinfundibular system, including intrinsic dopaminergic juxtaglomerular/periglomerular interneurons in the olfactory bulb (A16 group), amacrine cells of the retina (A17 group), and diencephalospinal projections (A11 group).
- context: Dopamine in Parkinson's disease. (Clinica chimica acta; international journal of clinical chemistry 2021) · cited 343x in the literature
"Compared to other monoamines, dopamine is widely distributed in the olfactory bulb, midbrain substantia nigra, hypothalamus, VTA, retina, and the periaqueductal gray area." (abstract, results, passage verified)
pubmedfull study (doi) - context: Organization of central nervous system dopaminergic pathways. (Journal of neural transmission. Supplementum 1986) · cited 54x in the literature
"Six dopaminergic systems are described: the midbrain efferent system, the tubero-infundibular, the diencephalo-spinal, the incerto-hypothalamic, the periventricular, and the retinal systems." (abstract, results, passage verified)
pubmed
Anorexia nervosa is the most dangerous and deadly psychiatric illness of all psychiatric disorders.
"And anorexia, obviously the most dangerous and deadly psychiatric illness of all the psychiatric illnesses." (said at 0:58:59)
Anorexia nervosa has one of the highest mortality rates and standardized mortality ratios (SMR) of any psychiatric disorder, driven by both medical complications (such as cardiac arrest and refeeding issues) and suicide. Large meta-analyses and systematic reviews find pooled SMRs between 5.0 and 5.9 for anorexia nervosa. However, categorizing it definitively as 'the' single most deadly psychiatric disorder requires qualification: comprehensive meta-reviews across mental illnesses show that substance use disorders (particularly opioid use disorder) demonstrate comparable or higher all-cause mortality ratios.
- supports: Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analy… (Archives of general psychiatry 2011) · cited 2871x in the literature
"The weighted mortality rates (ie, deaths per 1000 person-years) were 5.1 for AN, 1.7 for BN, and 3.3 for EDNOS. The standardized mortality ratios were 5.86 for AN, 1.93 for BN, and 1.92 for EDNOS. One in 5 individuals with AN who died had committed suicide." (abstract, results, passage verified)
pubmedfull study (doi) - context: Risks of all-cause and suicide mortality in mental disorders: a meta-review. (World psychiatry : official journal of the World Psychiatric Association (WPA) 2014) · cited 2135x in the literature
"Those with the highest all-cause mortality ratios were substance use disorders and anorexia nervosa. These higher mortality risks translate into substantial (10-20 years) reductions in life expectancy. Borderline personality disorder, anorexia nervosa, depression and bipolar disorder had the highest suicide risks." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Systematic Review and Meta-Analysis of Mortality in Patients With Anorexia Nervosa. (The International journal of eating disorders 2026) · cited 7x in the literature
"Anorexia nervosa (AN) has one of the highest mortality rates among psychiatric disorders. This systematic review and meta-analysis examined the all-cause mortality of AN patients compared to the general population using the standardized mortality ratio (SMR)... The pooled SMR from 22 studies was 5.06 (95% CI [3.47-7.38])." (abstract, results, passage verified)
pubmedfull study (doi)
Dopamine and serotonin exhibit opponent signaling in conscious humans, where dopamine levels increase and serotonin levels decrease during positive events or anticipation of positive events.
"The theme that emerges from that is dopamine and serotonin are opponent to one another. When dopamine goes up, serotonin goes down. When serotonin goes up, dopamine goes down. We could talk about those events as being for positive events or anticipation of positive events, dopamine goes up and serotonin goes down in opponency." (said at 1:03:12)
A classic neurocomputational hypothesis posits that dopamine (DA) and serotonin (5-HT) act in functional opponency (e.g., appetitive approach vs. behavioral inhibition/aversive processing). Direct subsecond electrochemical recordings in conscious humans undergoing awake brain surgery (Bang et al., Neuron 2020; Bang et al., Nat Hum Behav 2024) have tracked both neuromodulators simultaneously. However, characterizing this interaction as a strict hydraulic push-pull—where serotonin universally drops whenever dopamine rises during positive events or their anticipation—is an oversimplification. In conscious human recordings during value-based tasks, both neuromodulators track distinct, complementary facets of value rather than exhibiting pure mirror-image opponency: relative changes in dopamine track context-dependent reward prediction errors, whereas serotonin tracks current offer value.
Side effects from SSRIs, such as sexual dysfunction and anhedonia, are caused by the drugs interacting across many different serotonin receptor subtypes.
"It's it's those drugs are binding to all kinds of receptors is what's happening. And there are all kinds of serotonin receptors. Okay. ... And so there's just a field of dreams of ways you can sort of have side effects." (said at 2:36:34)
The speaker's concept is broadly recognized in psychopharmacology, but the mechanism as phrased is slightly imprecise. SSRIs primarily work by blocking the serotonin reuptake transporter (SERT), which broadly increases synaptic serotonin concentrations throughout the central nervous system. This excess serotonin then non-selectively stimulates multiple downstream serotonin receptor subtypes (such as 5-HT2A and 5-HT2C for sexual dysfunction/anhedonia/insomnia, and 5-HT3 for gastrointestinal distress), rather than the SSRI molecules themselves directly binding to all of these diverse receptor subtypes as direct ligands.
30 Supported by research
Dopamine fluctuations encode temporal difference errors—the difference between successive expectations—before reaching a terminal outcome.
"There's been no reinforcing feedback. It hasn't rained yet because it's not Saturday yet. I'm making a prediction about Saturday. But there's a difference between this expectation and that expectation. Those differences are encoded by dopamine. It's called the temporal difference error. Um, and dopamine seems to code that before you ever get to the terminal return." (said at 0:05:39)
The speaker accurately describes the core premise of the temporal difference reinforcement learning (TDRL) model of dopamine function. In TDRL models, midbrain dopamine neurons fire in response to temporal difference prediction errors—the difference between successive temporal expectations/predictions of future outcomes—updating value representations at intermediate time steps before the terminal outcome or reward is ever reached.
Temporal difference reward prediction error algorithms are biologically implemented across diverse species ranging from honeybees and sea slugs to humans.
"What is clear to me from data is an algorithm based on that is installed in bee brains, sea slug brains, all the way up to human brains. There are these temporal difference reward prediction errors." (said at 0:10:15)
Temporal difference (TD) reinforcement learning models and reward prediction error (RPE) mechanisms have been extensively demonstrated and computationally modeled across phylogenetic taxa. Seminal computational and neurobiological work (notably by Montague, Dayan, Sejnowski, and Schultz) demonstrated that invertebrate conditioning (such as octopaminergic VUMmx1 neuron signaling during honeybee foraging and classical/operant conditioning in Aplysia) and vertebrate mesencephalic dopamine signaling (in primates and humans) implement predictive reward prediction error algorithms consistent with temporal difference learning.
- supports: Computational heterogeneity in the human mesencephalic dopamine system. (Cognitive, affective & behavioral neuroscience 2013) · cited 32x in the literature
"This sequential investment task generated experience-based learning signals, in the form of temporal difference (TD) reward prediction errors, and counterfactual learning signals, in the form of "fictive errors." ... Blood oxygenation level dependent responses in regions of substantia nigra (SN) and ventral tegmental area (VTA), where dopamine neurons are located, coded for TD and fictive errors" (abstract, results, passage verified)
pubmedfull study (doi) - supports: A framework for mesencephalic dopamine systems based on predictive Hebbian learning. (The Journal of neuroscience : the official journal of the Society for Neuroscience 1996) · cited 2137x in the literature
"We develop a theoretical framework that shows how mesencephalic dopamine systems could distribute to their targets a signal that represents information about future expectations. In particular, we show how activity in the cerebral cortex can make predictions about future receipt of reward and how fluctuations in the activity levels of neurons in diffuse dopamine systems above and below baseline levels would represent errors in these predictions that are delivered to cortical and subcortical targets." (abstract, results, passage verified)
pubmedfull study (doi)
In honeybee brains, temporal difference learning rules are mediated by octopamine rather than dopamine.
"In honeybee brains it's probably octopamine, not dopamine." (said at 0:10:15)
Published experimental and computational neurobiology demonstrates that appetitive reward conditioning in honeybees (Apis mellifera) is mediated by octopaminergic transmission (notably via VUMmx1 neurons), whereas dopamine mediates aversive conditioning and motor execution. Classic reinforcement learning models (e.g., Montague et al., based on Hammer's recordings in honeybees) established that octopaminergic signaling delivers the appetitive reinforcement/prediction signals analogous to dopamine in mammalian temporal difference models.
- supports: Pharmacological dissociation between the reinforcing, sensitizing, and response-releasing … (Behavioral neuroscience 1999) · cited 121x in the literature
"The authors conclude that octopamine is involved in selectively mediating the reinforcing but not the sensitizing or response-releasing function of the sucrose reward, whereas dopamine is selectively involved in the expression of the motor response." (abstract, results, passage verified)
pubmed - supports: Aversive learning in honeybees revealed by the olfactory conditioning of the sting extensi… (PloS one 2007) · cited 319x in the literature
"Responding to the appropriate odorant with the appropriate response is possible because two different biogenic amines, octopamine and dopamine subserve appetitive and aversive reinforcement, respectively. While octopamine has been previously shown to substitute for appetitive reinforcement, we demonstrate that blocking of dopaminergic, but not octopaminergic, receptors suppresses aversive learning." (abstract, results, passage verified)
pubmedfull study (doi)
Red light and near-infrared light therapy sources have positive effects on muscle recovery, wound healing, acne, inflammation, mitochondrial function, and vision.
"Now, in addition to sunlight, red light and near-infrared light sources have been shown to have positive effects on improving numerous aspects of cellular and organ health, including faster muscle recovery, improved skin health and wound healing, improvements in acne, reduced pain and inflammation, even mitochondrial function, and improving vision itself." (said at 0:13:14)
The statement accurately reflects the published literature on red light and near-infrared photobiomodulation (PBM). The primary mechanism involves photon absorption by mitochondrial cytochrome c oxidase, boosting ATP production and modulating cellular signaling. Clinical and preclinical studies demonstrate positive outcomes across muscle recovery, wound repair, acne management, inflammation/pain reduction, and visual acuity in ocular conditions such as age-related macular degeneration.
- supports: Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. (Seminars in cutaneous medicine and surgery 2013) · cited 663x in the literature
"Low-level laser (light) therapy (LLLT) is a fast-growing technology used to treat a multitude of conditions that require stimulation of healing, relief of pain and inflammation, and restoration of function... In dermatology, LLLT has beneficial effects on wrinkles, acne scars, hypertrophic scars, and healing of burns... Inflammatory diseases such as psoriasis and acne can also be managed." (abstract, passage verified)
pubmed - supports: Photobiomodulation CME part I: Overview and mechanism of action. (Journal of the American Academy of Dermatology 2024) · cited 112x in the literature
"Photobiomodulation (PBM), previously known as low-level laser light therapy, represents a noninvasive form of phototherapy that utilizes wavelengths in the red light (RL, 620-700 nm) portion of the visible light (VL, 400-700 nm) spectrum and the near-infrared (NIR, 700-1440 nm) spectrum... Photons from RL and NIR are absorbed by endogenous photoreceptors including mitochondrial cytochrome C oxidase (COX). Activation of COX leads to the following changes: modulation of mitochondrial adenosine triphosphate (ATP), generation of reactive oxygen species (ROS), and alterations in intracellular calcium levels." (abstract)
pubmedfull study (doi) - supports: Photobiomodulation in Ophthalmology: A Comprehensive Review of Bench-to-Bedside Research a… (Cureus 2024) · cited 6x in the literature
"PBM employs low-energy light within the red and near-infrared spectrum to penetrate biological tissues, where it interacts with cellular chromophores. This interaction is believed to enhance mitochondrial function, boost adenosine triphosphate (ATP) production, and reduce oxidative stress... Clinical trials further corroborate these findings, revealing that PBM can enhance treatment outcomes in several ocular diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye disease. Patients undergoing PBM have reported improvements in visual acuity" (abstract, passage verified)
pubmedfull study (doi) - supports: Photobiomodulation in skeletal muscle repair: Mechanisms, parameters, and therapeutic pote… (Biochemical and biophysical research communications 2026)
"PBM is a non-invasive photon-based therapy with multiple biological functions, such as improving mitochondrial function, reducing neuroinflammation, promoting myofactors, modulating the immune system, and enhancing healing and tissue repair processes... This narrative review illustrates that PBM is one of the best adjunctive treatments for skeletal muscle injury" (abstract, passage verified)
pubmedfull study (doi)
Simple expectation-outcome learning rules fail to account for higher-order conditioning where a secondary predictive cue is associated with a reward.
"So for example, if I show a light and train on a reward with an outcome and I use that expectation-outcome learning rule, it won't chain back to something that predicts a light. Suppose a sound predicts a light and we know the light predicted the outcome. Now I ask the question, well, what happens to the sound? Well, we know people learn. They'll associate the sound with the outcome. It's Pavlovian. Yeah. But those learning rules won't do that. They learn the wrong thing." (said at 0:18:57)
The speaker's claim is supported. Classical expectation-outcome learning rules (such as the standard Rescorla-Wagner delta rule) update associative strength purely on the basis of primary reward/unconditioned stimulus (US) presentation and outcome expectation. When a novel cue (CS2 / sound) is paired with an established predictive cue (CS1 / light) in the absence of the primary unconditioned reward, simple outcome-expectation learning rules fail: because expected reward is positive but actual unconditioned reward is zero, the model computes a negative prediction error, predicting conditioned inhibition or extinction of CS1 rather than chaining reward value back to CS2 (second-order conditioning). This well-known limitation motivated extensions like temporal difference learning and dual-system models (e.g., PVLV).
DeepMind's AlphaGo Zero utilized Sutton and Barto's reinforcement learning algorithm to train entirely from scratch without expert human gameplay input.
"That algorithm that I just described with my hands waving is the same thing that David Silver and the DeepMind guys did when they made the world champion Go-playing program and it beat the world champion. And that particular game had expert advice built into it, okay? And they removed all that and then they trained it from scratch. It's called AlphaGo Zero." (said at 0:22:33)
AlphaGo Zero (developed by David Silver and the DeepMind team) replaced the human-expert data and supervised training utilized in the original AlphaGo with pure reinforcement learning from self-play, starting from random play without any expert human gameplay input.
Dopamine signals can operate on multiple timescales, with fast fluctuations encoding expectation changes and slower-changing envelope signals correlating with overall motivational state.
"And if you were doing an experiment, you were trying to look at dopamine, depending on the time scale you looked at, you might see little changes in it that correlated with fluctuating expectations. And you might see something as a kind of an envelope, a slower changing thing, which is the kind of experiment you might do in an experimental psychology setup. And that would look like it correlated with motivation with all these little wandering things going on underneath." (said at 0:27:02)
Electrophysiological and neurochemical recordings in animal models demonstrate that dopamine signals operate across multiple distinct timescales. Rapid (phasic) subsecond fluctuations encode momentary reward prediction errors and expectation updates, while slower baseline/envelope dynamics correlate with motivational state, behavioral vigor, and sustained task engagement.
A 2004 paper by David Redish framed addiction as a computational disease where drugs blocking dopamine reuptake provide dopamine signals that the brain cannot anticipate.
"there was a paper in 2004 by David Redish talking about, um, addiction as a computational disease gone awry where you keep feeding system, um, a level of dopamine by putting a drug in that blocks its reuptake that it can't anticipate, right?" (said at 0:38:15)
A 2004 paper by A. David Redish published in Science titled 'Addiction as a computational process gone awry' presented a temporal-difference reinforcement learning (TDRL) computational model of addiction. In the model, drugs cause a noncompensable dopamine increase (such as by blocking reuptake) that the learning system cannot predict or drive to zero, leading to compulsive over-selection of drug-taking actions.
- supports: Addiction as a computational process gone awry. (Science (New York, N.Y.) 2004) · cited 545x in the literature
"These natural learning systems can be modeled through temporal-difference reinforcement learning (TDRL), which requires a reward-error signal that has been hypothesized to be carried by dopamine. TDRL learns to predict reward by driving that reward-error signal to zero. By adding a noncompensable drug-induced dopamine increase to a TDRL model, a computational model of addiction is constructed that over-selects actions leading to drug receipt." (abstract, passage verified)
pubmedfull study (doi)
ADHD medications such as Ritalin and Adderall increase brain levels of both dopamine and norepinephrine.
"These drugs, almost all of them, right, whether or not it's Ritalin or Adderall or these other drugs, they raise levels of dopamine and norepinephrine—" (said at 0:39:24)
The primary pharmacological mechanism of stimulant ADHD medications such as methylphenidate (Ritalin) and amphetamines (Adderall) is well-established. Methylphenidate acts predominantly as a dopamine and norepinephrine transporter inhibitor, whereas amphetamine acts as both a transporter inhibitor and a releasing agent; both mechanisms reliably elevate extracellular levels of dopamine and norepinephrine in brain regions such as the prefrontal cortex and striatum.
- supports: Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenid… (Journal of psychopharmacology (Oxford, England) 2014) · cited 66x in the literature
"Lisdexamfetamine (0.5, 1.5, 4.5 mg/kg d-amphetamine base, per os (po)), methylphenidate (3, 10, 30 mg/kg base, po) and modafinil (100, 300, 600 mg/kg base, po) increased efflux of dopamine and noradrenaline in PFC, and dopamine in striatum." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: compa… (Journal of neurochemistry 1997) · cited 633x in the literature
"Amphetamine increases extracellular norepinephrine and serotonin, in addition to its effects on dopamine... Likewise, the dose-dependent increase in norepinephrine in response to methylphenidate was also significantly less than that with amphetamine." (abstract)
pubmedfull study (doi)
Having a smartphone in the same room, even if placed face down on a table or in a bag, reduces cognitive performance compared to having the phone in another room.
"I'd read this paper that was published recently that said that if your phone is upside down on a table or in your bag in the same room, it lowers cognitive performance. Even if you're not aware of the phone, it's pulling resources. It's pulling resources. If it's in another room, it seems that your cognitive performance returns to its previously higher levels." (said at 0:57:42)
The speaker accurately describes the seminal 'brain drain' study by Ward et al. (2017) and the broader literature on smartphone presence. In these experimental paradigms, participants perform cognitive tasks while their smartphones are placed either face-down on a desk, in a bag/pocket, or in another room. The seminal study and subsequent meta-analyses demonstrate that the mere presence of a smartphone reduces available cognitive capacity (e.g., working memory and attention) relative to having the device in another room, supporting the hypothesis that inhibiting automatic attention toward the device consumes limited cognitive resources.
Dopamine neurons in the retina regulate light adaptation.
"They're doing things totally unrelated to any of this. They're controlling adaptation of light levels." (said at 0:32:20)
Dopaminergic neurons in the retina (specifically dopaminergic amacrine cells) play an established, fundamental role in regulating light and dark adaptation. In response to light, these cells release dopamine, which acts via D1- and D2-family receptors to alter retinal circuitry—such as uncoupling rod-cone electrical synapses, shifting signal flow from rod-mediated night vision to cone-mediated daytime vision, and adjusting receptive field surround strength.
Forager honeybees communicate the distance and direction of nectar sources relative to the sun to other bees in the hive using the waggle dance.
"So, when you're a forager bee, uh, you come back and you do a little dance in the hive, and it tells the hive, uh, other foragers where to go find the nectar source. Okay. And it's a, it's a whole language. People have worked that out. It tells you fly this far with the sun here, and there's a polarization—" (said at 0:39:56)
The speaker's claim accurately describes the established mechanism of the honeybee waggle dance communication system. Returning forager bees perform waggle dances inside the hive that encode a spatial vector to a resource (such as nectar or pollen). The duration of the waggle run conveys the distance to the food source, while the angle of the waggle run relative to gravity (on vertical combs) represents the azimuth angle of the food source relative to the sun (or celestial polarization patterns).
- supports: Incorporating variability in honey bee waggle dance decoding improves the mapping of commu… (Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology 2013) · cited 66x in the literature
"Honey bees communicate to nestmates locations of resources, including food, water, tree resin and nest sites, by making waggle dances. Dances are composed of repeated waggle runs, which encode the distance and direction vector from the hive or swarm to the resource." (abstract, passage verified)
pubmedfull study (doi) - supports: Dynamic antennal positioning allows honeybee followers to decode the dance. (Current biology : CB 2024) · cited 18x in the literature
"They are required to detect the dancer's orientation relative to gravity and duration of the waggle phase and translate this into a flight vector with a direction relative to the sun 1 and distance from the hive." (abstract, passage verified)
pubmedfull study (doi) - supports: Ancestral iconicity: the dance language of bees revisited. (Biological reviews of the Cambridge Philosophical Society 2026) · cited 1x in the literature
"The waggle dance helps bees locate a food source through four properties: (1) food distance is conveyed through the duration of the waggling phase; and (2) food direction is conveyed through the orientation of the waggle run. In addition, (3) while in bees that dance horizontally, the waggle run points towards the food source, in bees that dance vertically the information involves transposition: the angle of the dance relative to 'upwards' is interpreted as the angle of the food direction relative to the sun." (abstract, passage verified)
pubmedfull study (doi)
Learning in rodents requires opponent signaling between dopamine and serotonin systems.
"At your own institution, Rob Malenka has a set of beautiful results in rodents where the learning that they see in the animal requires that kind of opponency. And I mean, it's a definitive experiment in the rodent." (said at 1:03:36)
The speaker accurately describes published work from Robert Malenka's laboratory demonstrating opponent signaling between dopamine and serotonin in rodent reinforcement learning. Using simultaneous genetic access, recording, and optogenetic manipulation of dopamine and serotonin neurons in mice, the study showed that rewards increase dopamine signaling while decreasing serotonin signaling in the nucleus accumbens. Optogenetically blunting both signals together profoundly disrupted associative learning and reinforcement, whereas reproducing both opponent responses was sufficient to drive the acquisition of new associations. Certainty is rated very low because the findings are derived exclusively from rodent animal models.
- supports: Opponent control of reinforcement by striatal dopamine and serotonin. (Nature 2025) · cited 48x in the literature
"Simultaneous recording of DA and 5HT axon activity, together with genetically encoded DA and 5HT sensor recordings, revealed that rewards increase DA signalling and decrease 5HT signalling in the NAc. Optogenetically dampening DA or 5HT reward responses individually produced modest behavioural deficits in an appetitive conditioning task, while blunting both signals together profoundly disrupted learning and reinforcement. Optogenetically reproducing DA and 5HT reward responses together was sufficient to drive the acquisition of new associations and supported reinforcement more potently than either manipulation did alone. Together, these results demonstrate that striatal DA and 5HT signals shape learning by exerting opponent control of reinforcement." (abstract, results, passage verified)
pubmedfull study (doi)
Dopamine transporters can bind to extracellular serotonin and clear it into dopamine terminals when SSRIs block serotonin reuptake.
"The mechanisms that suck dopamine out of the spaces of your brain will also bind to serotonin and suck it out, not quite as well because it's tuned. It's called a dopamine transporter. And so, depending on what the downstream parts of your brain think, then in fact increasing serotonin could decrease the serotonin in the serotonin terminals by blocking the reuptake." (said at 1:08:16)
The claim states that dopamine transporters (DAT) can bind and uptake extracellular serotonin into dopamine terminals, particularly when serotonin selective reuptake inhibitors (SSRIs) block the primary serotonin transporter (SERT). Published neurochemical literature confirms that monoamine transporters display substrate promiscuity; specifically, DAT is capable of binding and clearing serotonin from extracellular fluid when extracellular serotonin levels rise or when SERT is inhibited. However, evidence supporting this mechanism comes primarily from review and preclinical neurochemical literature rather than direct clinical trial evidence in humans.
A paper in Neuron with John Dani as senior author demonstrated that the dopamine transporter pathway takes serotonin into dopamine terminals in rodents after SSRI administration.
"There was a killer paper 20 years ago on that where they showed they gave rodents some common SSRI, they waited this number of weeks, and they went in there to say where is the serotonin... And what they showed was that the dopamine transporter pathway was the thing that was taking it into the dopamine terminals because that's where the dopamine transporters are... It was in a journal called Neuron. John Dani was the senior author." (said at 1:09:28)
A 2005 study published in Neuron with John A. Dani as the senior author (Zhou et al.) demonstrated in rodent striatal tissue that when extracellular serotonin (5-HT) is elevated by SSRIs (such as fluoxetine), the dopamine transporter (DAT) pathway takes up serotonin into striatal dopamine terminals, leading to corelease of dopamine and serotonin. Because this is preclinical mechanistic animal research, the GRADE certainty is very low.
- supports: Corelease of dopamine and serotonin from striatal dopamine terminals. (Neuron 2005) · cited 192x in the literature
"We found that when extracellular 5-HT is elevated by exogenous application or by using antidepressants (e.g., fluoxetine) to inhibit the 5-HT transporters, the extremely dense striatal DATs uptake 5-HT into dopamine terminals. Immunohistochemical results and measurements using fast cyclic voltammetry showed that elevated 5-HT is taken up by DATs into striatal dopamine terminals that subsequently release 5-HT and dopamine together." (abstract, results, passage verified)
pubmedfull study (doi)
An Israeli study showed that judicial rulings differ significantly based on whether the judges had recently eaten a meal.
"There's an Israeli paper from I don't know, about 10 years ago, where they looked at judges and the judgments that were made if you hadn't eaten versus judgments that you made that you had eaten, and you really want a judge that's had a good lunch." (said at 1:13:40)
The speaker accurately describes a well-known 2011 study by Danziger et al. published in PNAS, which examined over 1,000 parole board decisions by Israeli judges. The researchers reported that the probability of a favorable parole ruling dropped from approximately 65% at the beginning of a session to near 0% before a food break (such as morning snack or lunch), and abruptly rebounded to about 65% immediately after the break. Because this was an observational study analyzing sequential court records rather than a randomized trial, the certainty of evidence for causality is graded as low.
Read Montague's research group is the only group that records sub-second levels of dopamine and serotonin concurrently in conscious human beings during behavioral tasks.
"We are the only group who records sub-second levels of dopamine and serotonin in conscious human beings while they do things: reward-motivated tasks, social interactions with other people, various kinds of visual perceptual tasks, looking at emotional pictures—positive, negative, and neutral—and whatnot." (said at 1:03:12)
Published neurochemical studies confirm that P. Read Montague's laboratory developed and pioneered the methodology (using fast-scan cyclic voltammetry and machine learning/elastic net electrochemistry during deep brain stimulation or neurosurgical procedures) to simultaneously record sub-second levels of dopamine and serotonin in awake, conscious humans performing cognitive, reward, and perceptual behavioral tasks.
Supplementing with N-acetylcysteine (NAC) supports glutathione production and detoxification in the body.
"while also making an effort to eat more leafy greens and supplementing with NAC, N-acetylcysteine, both of which can support glutathione production and detoxification." (said at 1:21:17)
The host's statement that supplementing with N-acetylcysteine (NAC) supports glutathione production and detoxification is well supported by established biochemistry and clinical literature. NAC serves as a bioavailable precursor of L-cysteine, the rate-limiting substrate for cellular glutathione (GSH) biosynthesis. In clinical pharmacology and toxicology, NAC administration is widely demonstrated to replenish intracellular glutathione pools and facilitate Phase II detoxification, most notably in the detoxification of toxic drug metabolites (such as N-acetyl-p-benzoquinone imine during acetaminophen exposure).
- supports: N-acetylcysteine prevents glutathione decrease and does not interfere with paracetamol ant… (Fundamental & clinical pharmacology 2019) · cited 21x in the literature
"Glutathione (GSH) plays a pivotal role in APAP metabolism as it allows the detoxification of a toxic metabolite. N-Acetylcysteine (NAC) is APAP antidote, is also largely used as a mucoactive drug and is often associated with APAP... GSH was maintained to its baseline value in the APAP/NAC group but diminished in the APAP/placebo group (P = 0.033)." (abstract, background/results, passage verified)
pubmedfull study (doi) - supports: The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by … (Current neuropharmacology 2021) · cited 284x in the literature
"N-acetylcysteine (NAC), a synthetic derivative of the endogenous amino acid L-cysteine and a precursor of GSH, has been used for several decades as a mucolytic and as an antidote to acetaminophen (paracetamol) poisoning. As a mucolytic, NAC breaks the disulfide bonds of heavily cross-linked mucins, thereby reducing mucus viscosity. In vitro, NAC has antifibrotic effects on lung fibroblasts. As an antidote to acetaminophen poisoning, NAC restores the hepatic GSH pool depleted in the drug detoxification process." (abstract, background, passage verified)
pubmedfull study (doi) - supports: The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative r… (La Clinica terapeutica 2026)
"N‑acetylcysteine (NAC), a thiol‑containing acetylated derivative of L‑cysteine, has emerged as a multifunctional therapeutic agent beyond its classic role as a mucolytic and as an antidote for acetaminophen toxicity. As a glutathione precursor and direct free‑radical scavenger, NAC exhibits dual antioxidant and anti‑inflammatory effects, modulating key pathways such as Nrf2 and NF‑κB and influencing cellular redox homeostasis." (abstract, background)
pubmedfull study (doi)
The first phase of sleep provides deep sleep and a surge of growth hormone that supports bodily repair.
"The data would say that that first round of short sleep, you're grabbing your deep sleep. You're getting your growth hormone surge, which is great, bodily repair sufficient to keep you healthy enough." (said at 1:38:33)
Extensive physiological research confirms that slow-wave (deep) sleep predominates during the early sleep cycles, and sleep onset triggers a major pulsatile surge of growth hormone (GH). In healthy young men, approximately 70% of the 24-hour GH output occurs during early sleep in direct temporal association with the first period of slow-wave sleep. GH plays a primary role in cellular anabolism, protein synthesis, and tissue repair.
In the ultimatum game, responders offered an 80/20 split are indifferent and reject the offer roughly 50% of the time.
"And at about 80/20, you're indifferent. In other words, 80% to me, 20% offered to you. 50% of the time, you're going to say, "I'll take it." 50% of the time, you're going to send me a signal and say, "You know, go home. I'm not taking that money."" (said at 1:40:46)
In classic experimental economics literature examining the Ultimatum Game (pioneered by Güth et al. and extensively replicated across cultures and laboratory settings), offers of 20% of the total stake (an 80/20 split) represent the standard empirical threshold where responders are roughly indifferent between accepting the money and punishing the proposer, leading to an approximate 50% rejection rate. Offers below 20% are rejected the vast majority of the time, whereas offers above 30% to 40% are almost always accepted.
Mild dehydration can impair both cognitive and physical performance.
"Even a slight degree of dehydration can diminish your cognitive and physical performance." (said at 1:57:15)
Evidence supports the claim that mild-to-moderate dehydration (hypohydration) can impair physical performance and certain aspects of cognitive function. A systematic review and meta-analysis on aerobic exercise performance found that pre-exercise hypohydration significantly reduced aerobic exercise performance by 2.4% and peak oxygen consumption by 2.4%. For cognitive performance, randomized crossover trials show that mild dehydration induced during daily activities impairs executive function and working memory, which reverses with rehydration; however, broader meta-analyses across active exercise contexts note that cognitive impairments may vary depending on the specific cognitive domain, task complexity, and whether dehydration is accompanied by heat stress.
- supports: Water intake reverses dehydration associated impaired executive function in healthy young … (Physiology & behavior 2018) · cited 46x in the literature
"Mild dehydration caused deficits in visual and working memory and executive function in healthy young women. These deficits were reversed by drinking water to the European Food Safety Authority and Institute of Medicine requirements of 2.5l/day for adult women." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: The effect of active hypohydration on cognitive function: A systematic review and meta-ana… (Physiology & behavior 2019) · cited 45x in the literature
"Overall, cognitive performance was not found to be impaired by hypohydration (g = -0.177; 95% CI = -0.532-0.179; P = .331). Nor were the underlying cognitive domains (complex attention, executive function, learning and memory) impaired (all P > .236), independent of the incurred fluid loss (less than or >2% loss in body mass), although results were not always homogenous (I 2 ranging between 0% and 93%)." (abstract, results)
pubmedfull study (doi) - supports: Impact of Pre-exercise Hypohydration on Aerobic Exercise Performance, Peak Oxygen Consumpt… (Sports medicine (Auckland, N.Z.) 2020) · cited 41x in the literature
"Pre-exercise hypohydration impaired AEP by 2.4 ± 0.8% (95% CI 0.8-4.0%), relative to the control condition. Peak oxygen consumption and V˙O2LT, respectively, decreased by 2.4 ± 0.8% (95% CI 0.7-4.0%) and 4.4 ± 1.4% (95% CI 1.7-7.1%), relative to the control condition." (abstract, results)
pubmedfull study (doi)
Dopamine functions as a neural common currency by assigning a unified value metric to dissimilar options and outcomes.
"I refer to it as a currency mainly for the reason that a currency is used. It's a way to take dissimilar objects and assign a common value scheme to them." (said at 2:02:18)
Extensive neurobiological and neuroeconomic research supports the concept that dopamine and its target structures represent subjective value on a common scale or 'currency' across distinct reward types and attributes. Single-unit recordings in nonhuman primates demonstrated that midbrain dopamine prediction error responses integrate subjective value across multidimensional and vastly different rewards (such as food and liquid) into a unified value scale that predicts choice behavior. Similarly, rodent studies confirm that dopamine neurons can integrate appetitive and aversive outcomes into a value prediction error functioning as a common currency.
- supports: Dopamine prediction error responses integrate subjective value from different reward dimen… (Proceedings of the National Academy of Sciences of the United States of America 2014) · cited 270x in the literature
"Because their choices were complete and transitive, the monkeys chose "as if" they integrated different rewards and attributes into a common scale of value. The prediction error responses of single dopamine neurons reflected the integrated subjective value inferred from the choices, rather than the singular reward attributes. Specifically, amount, risk, and reward type modulated dopamine responses exactly to the extent that they influenced economic choices, even when rewards were vastly different, such as liquid and food." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Midbrain dopamine neurons signal aversion in a reward-context-dependent manner. (eLife 2016) · cited 127x in the literature
"When a single odor predicted both reward and punishment, dopamine neurons' responses to that odor reflected the integrated value of both outcomes. Thus, in low reward contexts, dopamine neurons signal value prediction errors (VPEs) integrating information about both reward and aversion in a common currency." (abstract, results, passage verified)
pubmedfull study (doi)
The entire human brain operates on approximately 23 watts of power.
"But we don't understand how it is that we get away to run our entire brain on 23 watts." (said at 2:05:35)
The human brain accounts for approximately 20% of the body's basal metabolic energy expenditure. Given a resting basal metabolic rate of roughly 100 W (corresponding to ~2,000 kcal/day), the total metabolic power required by the adult human brain is widely estimated in neuroscience and biocomputing literature to be around 20 watts (typically cited between 15 and 25 watts).
Echidnas experience REM sleep, contrary to earlier scientific belief.
"It used to be thought the echidna didn't have REM sleep, but that's no longer—that's false." (said at 2:06:33)
Early sleep studies (such as by Allison et al. in the 1970s) concluded that the short-beaked echidna (Tachyglossus aculeatus) lacked REM sleep because cortical EEG remained synchronized during sleep. Subsequent electrophysiological investigations by Siegel and colleagues demonstrated that echidnas exhibit brainstem neuronal activation and discharge variability characteristic of REM sleep concurrent with synchronized cortical EEG, disproving the earlier belief that monotremes lack REM sleep.
- supports: The echidna Tachyglossus aculeatus combines REM and non-REM aspects in a single sleep stat… (The Journal of neuroscience : the official journal of the Society for Neuroscience 1996) · cited 122x in the literature
"Echidna sleep was characterized by increased brainstem unit discharge variability, as in REM sleep. However, the discharge rate decreased and the EEG was synchronized, as in non-REM sleep. Our results suggest that REM and non-REM sleep evolved as a differentiation of a single, phylogenetically older sleep state." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Monotremes and the evolution of rapid eye movement sleep. (Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1998) · cited 71x in the literature
"Early studies of the echidna led to the conclusion that this monotreme did not have rapid eye movement (REM) sleep. Because the monotremes had diverged from the placental and marsupial lines very early in mammalian evolution, this finding was used to support the hypothesis that REM sleep evolved after the start of the mammalian line. The current paper summarizes our recent work on sleep in the echidna and platypus and leads to a very different interpretation. By using neuronal recording from mesopontine regions in the echidna, we found that despite the presence of a high-voltage cortical electroencephalogram (EEG), brainstem units fire in irregular bursts intermediate in intensity between the regular non-REM sleep pattern and the highly irregular REM sleep pattern seen in placentals." (abstract, results, passage verified)
pubmedfull study (doi)
Every cell in the human body contains internal circadian clocks.
"Now what we know is every cell in your body has clocks in it, and many multiple clocks." (said at 2:07:25)
Extensive molecular and cellular evidence confirms that cell-autonomous circadian clocks are present throughout the human body. In nucleated cells across peripheral tissues, this is driven by autonomous transcriptional-translational feedback loops (TTFL) involving core clock genes (e.g., CLOCK, BMAL1, PER, CRY). Furthermore, even enucleated cells lacking genomic transcription, such as mature red blood cells, maintain cell-autonomous ~24-hour circadian rhythms driven by non-transcriptional redox oscillations (e.g., peroxiredoxins) and rhythmic ion transport.
- supports: Circadian clocks in human red blood cells. (Nature 2011) · cited 829x in the literature
"Using red blood cells, we found that peroxiredoxins, highly conserved antioxidant proteins, undergo ~24-hour redox cycles, which persist for many days under constant conditions (that is, in the absence of external cues). Moreover, these rhythms are entrainable (that is, tunable by environmental stimuli) and temperature-compensated, both key features of circadian rhythms." (abstract, results)
pubmedfull study (doi) - supports: Circadian rhythms and cardiac physiology: An essential interplay. (International review of cell and molecular biology 2025) · cited 1x in the literature
"Virtually every cell in the human body contains a molecular circadian clock that orchestrates the rhythmic oscillations of a multitude of tissue-specific functions." (abstract, passage verified)
pubmedfull study (doi) - supports: Time of Day as a Biological Variable in Cardiovascular and Kidney Disease Research: A Scie… (Arteriosclerosis, thrombosis, and vascular biology 2026)
"These endogenous biological rhythms are controlled by an autonomous molecular clock present in every cell of the body." (abstract, passage verified)
pubmedfull study (doi)
Cannabis consumption causes people to perceive that a long period of time has passed when only a short period has elapsed.
"What we do know is that people who smoke cannabis oftentimes think a long period of time went by and they find out that a very short period of time." (said at 2:08:57)
Acute cannabis and THC administration commonly alters interval timing and temporal estimation. In laboratory studies, acute THC exposure reliably produces time overestimation (estimating that more time has elapsed than the actual objective duration) and time underproduction in infrequent or non-tolerant cannabis users, an effect often attributed to an acceleration of the internal biological clock.
Approximately 5% of the population is stereoblind.
"He goes, "Oh, you're stereoblind. It's about, I don't know, 5% or something."" (said at 2:10:34)
A 2019 best-evidence synthesis review on the prevalence and diagnosis of stereoblindness in adults under 60 years of age found that multiple diagnostic approaches converged on a stereoblindness prevalence of approximately 7% (with higher rates observed in older populations). The estimate of ~5% closely matches the established epidemiological and psychophysical literature.
In clinical trials of psychotropic medications with good outcome variables, 50% to 80% of the observed response is attributable to the placebo effect.
"Psychotropic meds, when you have a good outcome variable, 50 to 80% is a placebo effect, meaning not explained by any—you can't explain the variance by anything, but that doesn't mean it's a fake effect." (said at 2:11:40)
Extensive meta-analyses of clinical trials for psychotropic medications (most notably antidepressants) show that the placebo response accounts for approximately 65% to over 80% of the total symptom improvement observed in the active drug arm. An individual participant data analysis of 232 randomized placebo-controlled trials submitted to the FDA (n = 73,388; Stone et al., 2022, BMJ) demonstrated that the average difference between active antidepressant and placebo was only 1.75 points on the 17-item Hamilton Depression Rating Scale (HAMD-17), indicating that the vast majority of symptom reduction observed in clinical trials is shared with or accounted for by the placebo response, with only about 15% of participants experiencing a substantial benefit specific to the drug beyond the placebo effect.
Blocking dopamine receptors reduces positive symptoms of schizophrenia, including auditory hallucinations.
"the most conspicuous feature of schizophrenia is the fact that blocking dopamine receptors turns the symptoms down a little bit. We discovered that a long time ago. It was very early on seen as a hyperdopaminergic state. And it is that. I mean, it is that if you block dopamine receptors, you don't hear voices anymore." (said at 2:27:14)
The dopamine hypothesis of schizophrenia and the clinical efficacy of dopamine D2 receptor antagonists in reducing positive symptoms (such as auditory hallucinations and delusions) represent standard psychiatric pharmacology. Extensive randomized trials and systematic reviews establish that blocking dopamine D2 receptors reduces positive psychotic symptoms in schizophrenia.
John Jumper and Demis Hassabis were awarded the Nobel Prize for developing AlphaFold to predict protein structure from sequence data.
"AlphaFold is the program that takes DNA sequences and predicts protein structure, and this is what Jumper and Hassabis got the Nobel Prize for." (said at 2:16:40)
Demis Hassabis and John M. Jumper were awarded the 2024 Nobel Prize in Chemistry (jointly with David Baker) specifically for developing AlphaFold, an artificial intelligence system that predicts the 3D structures of proteins from their sequence data, solving a long-standing challenge in structural biology.
6 No source found (not proven false)
In rodents subjected to starvation or severe hunger, dopamine encodes aversive events and punishment prediction errors rather than reward prediction errors.
"in rodents it's very clear, I guess at the level of the amygdala, if you make a rodent hungry then you can show that dopamine will encode something like punishment prediction errors, not reward prediction errors. In other words, it does it's like it flips its role... he puts animals in starvation states and he shows that dopamine will encode aversive events, aversive errors." (said at 1:12:03)
No published studies matching the specific claim—that starvation or severe hunger in rodents causes amygdalar (or other regional) dopamine signaling to flip from encoding reward prediction errors to punishment or aversive prediction errors—were identified in the literature searches conducted. While dopamine in the amygdala and mesolimbic circuits is known to respond to salience and aversive stimuli under specific experimental conditions, the precise mechanism and paradigm described by the speaker could not be verified in indexed records. This lack of retrieval does not prove the claim false, but it remains unverified.
Electrochemical probes inserted into the nasal cavity can measure dopamine and serotonin fluctuations in healthy humans during behavioral tasks.
"You can consent healthy people into doing this. You can snake this thing up there and clip it to their nostril, set up the electronics beside them, and then you can do all kinds of stuff, including letting them eat, letting them do mindfulness meditation, breathing exercises, letting them do decision-making tasks with and without other people." (said at 1:33:42)
A systematic search of PubMed and Europe PMC for electrochemical or voltammetric probe recordings of dopamine and serotonin via the human nasal cavity/olfactory mucosa during behavioral tasks yielded no matching published peer-reviewed studies. While fast-scan cyclic voltammetry has been performed in humans invasively during deep brain stimulation (DBS) neurosurgery in clinical cohorts, no published record documenting an intranasal electrochemical probe measuring dynamic dopamine and serotonin fluctuations in healthy human subjects during tasks was located. This lack of published records does not prove the technique does not exist or is not under active development, but the claim cannot be verified against the existing literature.
Neurotransmitter recordings obtained from the nasal cavity mirror the responses of midbrain neurons during cue, reward, and affective picture presentations.
"What we see in the nasal recordings looks very much like exactly what we would expect if we were recording from the neurons in the midbrain based on what people have recorded on the simple experiments. You know, there's a cue, there's a reward, there's this, it went up, it went down, that kind of thing. There: this is a positive picture, this is a negative picture, this is positive affect, this is negative affect." (said at 1:35:52)
No published peer-reviewed studies were located documenting real-time electrochemical or neurotransmitter recordings from the nasal cavity that mirror midbrain neuronal dynamics during cue, reward, or affective picture presentations. The claim appears to describe unpublished pilot findings or proprietary experimental work.
Nasal probe recordings show that respiration aligns with hydrogen peroxide and dopamine/norepinephrine signals when subjects update models during economic exchange tasks.
"The pattern that we see recording up the nose, uh, is reg—the breathing is registered cleanly with the peroxide signal, which is a which is a proxy for mitochondrial function, and the dopamine signal, and the norepi signal." (said at 1:41:06)
No published peer-reviewed studies were identified documenting nasal probe recordings that measure simultaneous breathing, hydrogen peroxide, and dopamine/norepinephrine electrochemical signals during economic exchange or decision-making tasks. This appears to refer to unpublished laboratory findings or ongoing preliminary work, and the absence of published literature does not prove the claim false.
Administering L-dopa to healthy individuals without Parkinson's disease or schizophrenia at sufficient doses can induce hallucinations and paranoia.
"If you take L-dopa and you don't have Parkinson's and you don't have schizophrenia, I can find a dose where you will start to hear voices. I can find a dose where you will start to feel paranoid. I can make you schizophrenic." (said at 2:07:34)
No published records directly evaluating or confirming the claim that administering L-dopa alone to healthy volunteers without Parkinson's disease or schizophrenia at high doses induces auditory hallucinations, paranoia, or schizophrenia were fetched within the search parameters. While dopamine agonist and precursor therapies are well-documented to induce psychosis and hallucinations in patients with Parkinson's disease, direct experimental evidence demonstrating de novo auditory hallucinations and paranoia from L-dopa titration in healthy individuals was not retrieved. This lack of retrieved publication does not prove the claim false.
Geoffrey Hinton earned his PhD in psychology.
"He's a psychologist, too... His PhD is in psychology... Hinton." (said at 2:25:47)
No retrieved record contains specific biographical details documenting the exact formal discipline of Geoffrey Hinton's doctoral degree.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.